<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:department>Molecular Medicine</gtr:department><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F6616A73-C8B7-4809-8F4B-36D177DCCF33"><gtr:id>F6616A73-C8B7-4809-8F4B-36D177DCCF33</gtr:id><gtr:firstName>Li</gtr:firstName><gtr:surname>Wei</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G106%2F1249"><gtr:id>F721024D-4C6F-494B-990E-567A5AEB54C3</gtr:id><gtr:title>Epidemiology of drug compliance, safety monitoring and outcome of cardiovascular drugs prescribed in primary care</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G106/1249</gtr:grantReference><gtr:abstractText>There is evidence to show that medication management in cardiovascular disease is sub-optimal and relates to physician inertia and patient?s poor compliance with therapy. The elderly, with high rates of co-morbidity and co-prescribing are at particular risk of unwanted adverse effects from drugs. The proposed project aims to evaluate medication management in term of compliance, safety monitoring and clinical outcome in post MI patients. Several perspectives such as patient behaviour (compliance), doctor behaviour (prescribing) and drug behaviour (interactions and toxicity) will be evaluated. Studies that provide real world data on medication management for post MI patients will help us to better understand the risk /benefit of drug treatment and to improve delivery of the health service in the primary care setting.</gtr:abstractText><gtr:technicalSummary>Aims and Objectives:
The proposed project aims to evaluate the outcome of dispensed prescribing drugs in post myocardial infarction patients in term of compliance, co-prescribing, co-morbidity and mortality. The specific objectives are: 1) to determine the pattern of the drug compliance for each drug use (aspirin, statins, ACE inhibitors,and beta-blockers) and their combination use in post MI patients in primary care setting and to examine the compliance trends over a 10 year period and to estimate the effect of compliance on cardiovascular outcome; 2) to determine the pattern of the spironolactone use and to examine the short, medium and long term safety profile of spironolactone in clinical practice; 3) to investigate whether post MI patients with heart failure who take statins have increased risks of hospitalisation for heart failure or death; 4) to examine whether allopurinol is associated with any alternation in mortality and hospitalizations in post MI patients with heart failure.
Plan:
Study design A series observational studies of prescribed drugs and outcome in post MI patients Study population Subjects resident in Tayside and registered with a general practitioner between January 1993 and December 2004 will form the study population. These subjects are residents of Tayside throughout the study period, or may die during the study period. Study subjects All subjects who experienced their first MI hospitalisation between January 1989 and December 2004 will form the study. Prescribing data, hospitalization data and biochemistry will be collected on each subject until 31 December 2004. Outcome variables The outcomes of the study will be hospitalisation for cardiovascular events or hyperkalemia or renal failure or all cause mortality during the study period. Statistical analysis Data will be summarised as mean (standard deviation) for continuous variables and number of subjects (percent) for categorical variables. Chi-square and t tests will be performed to determine significant differences. Multivariable regression models will be used in this project. 
Opportunities:
The results of the project will be directly relevant to NHS service delivery and will add value to current medication management research in post MI patients. It is envisaged that the outputs from the research component of this fellowship will also have implications for future health service policy and guideline recommendations concerning drug monitoring in post MI patients.</gtr:technicalSummary><gtr:fund><gtr:end>2008-08-27</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-08-28</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>145767</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>conference</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>98238C7A-F702-46EE-97C4-5A2CC22662BF</gtr:id><gtr:impact>Oral presentation at 9th Congress of European Association for Clinical Pharmacology Therapeutics, Edinburgh

high interest from the audience</gtr:impact><gtr:outcomeId>DHDPdGdeN2V</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2048840</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Health Technology Assessment Programme (HTA)</gtr:department><gtr:description>Allopurinol and Cardiovascular outcomes in Patients with Ischaemic Heart Disease</gtr:description><gtr:end>2019-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>11/36/41</gtr:fundingRef><gtr:id>6D7D5CF7-86FE-4251-B4B6-2B64F8E466F3</gtr:id><gtr:outcomeId>iiqMCJrsfqX</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>104707</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>BUPA Foundation</gtr:department><gtr:description>project grant</gtr:description><gtr:end>2012-02-02</gtr:end><gtr:fundingOrg>BUPA</gtr:fundingOrg><gtr:id>573DC711-8B72-4641-B2BB-40CCAE40861B</gtr:id><gtr:outcomeId>dEXFahMxsBz0</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2010-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>105000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>project grant</gtr:description><gtr:fundingOrg>Novartis</gtr:fundingOrg><gtr:id>715D9346-BC20-4C76-82F0-61A44697033C</gtr:id><gtr:outcomeId>XWkruh9dBsY</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2012-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>49727</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>project grant</gtr:description><gtr:end>2012-04-02</gtr:end><gtr:fundingOrg>Chief Scientist Office (CSO)</gtr:fundingOrg><gtr:id>3AE939D4-D938-4CA5-B3A3-A5F6ACEC5EB0</gtr:id><gtr:outcomeId>pAeViGETFT60</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>8700</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>project grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Tenovus Scotland</gtr:fundingOrg><gtr:id>99532F9A-EAF4-4AA9-B1C5-B1A395566309</gtr:id><gtr:outcomeId>Q488umGuDPc0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>9943</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>project grant</gtr:description><gtr:end>2008-09-02</gtr:end><gtr:fundingOrg>Tenovus Scotland</gtr:fundingOrg><gtr:id>5A2F1CA3-693B-4AE7-B10F-6B05DCA154BA</gtr:id><gtr:outcomeId>90859F7192A0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>project grant</gtr:description><gtr:end>2012-05-02</gtr:end><gtr:fundingOrg>Tenovus Scotland</gtr:fundingOrg><gtr:id>BA6F6510-6EDE-4C89-BEE4-7211C21C21CB</gtr:id><gtr:outcomeId>F6dfU36Nw9F0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>120710</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>BUPA Foundation</gtr:department><gtr:description>project grant</gtr:description><gtr:end>2009-05-02</gtr:end><gtr:fundingOrg>BUPA</gtr:fundingOrg><gtr:id>ECBFCA12-DADA-4C7D-BC15-E988FA4E9096</gtr:id><gtr:outcomeId>kTmJ2SKgNmY0</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2007-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>246133</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Experimental Medicine Call</gtr:description><gtr:end>2011-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>2D03CA2D-B71E-476C-AE7C-63F584BEFA00</gtr:id><gtr:outcomeId>tpnf1uQfZCD0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>9850</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>project grant</gtr:description><gtr:end>2011-06-02</gtr:end><gtr:fundingOrg>Tenovus Scotland</gtr:fundingOrg><gtr:id>BD7412A4-3658-4EF3-9D0F-E3A634B98F5C</gtr:id><gtr:outcomeId>mxo4DQtW16w0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>96437</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:fundingOrg>Novartis</gtr:fundingOrg><gtr:id>9C7CAE38-5F38-430F-ACFD-1958E00A85D3</gtr:id><gtr:outcomeId>K9NaTL7SNZZ</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2012-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ART Project grant</gtr:description><gtr:end>2009-09-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>365A4208-0526-4D60-8129-BEC2E4C7C790</gtr:id><gtr:outcomeId>DRomrxtEPSv0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MHRA and EMA reviewed the pioglitazone and bladder cancer study</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>4B5A1378-DF54-47B0-B6F9-06E0381BF7C5</gtr:id><gtr:outcomeId>gsF4mNKkXHf</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>F732C822-F8FA-4985-B3D9-6B273157FE08</gtr:id><gtr:title>Appendicectomy is associated with increased pregnancy rate: a cohort study.</gtr:title><gtr:parentPublicationTitle>Annals of surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6896965694e7fbd859e84e527852135a"><gtr:id>6896965694e7fbd859e84e527852135a</gtr:id><gtr:otherNames>Wei L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0003-4932</gtr:issn><gtr:outcomeId>pm_16060_20_23154396</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4647FA2D-3A3B-494E-922A-34913ED63511</gtr:id><gtr:title>High sensitivity troponin T provides useful prognostic information in non-acute chest pain.</gtr:title><gtr:parentPublicationTitle>QJM : monthly journal of the Association of Physicians</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/04612eb13fa31d0236e102d8529322f2"><gtr:id>04612eb13fa31d0236e102d8529322f2</gtr:id><gtr:otherNames>George J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1460-2393</gtr:issn><gtr:outcomeId>WxC18Eo4QGr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0AE21B8D-D2BA-40C8-BA35-44A01E807F1B</gtr:id><gtr:title>Spironolactone use and renal toxicity: population based longitudinal analysis.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6896965694e7fbd859e84e527852135a"><gtr:id>6896965694e7fbd859e84e527852135a</gtr:id><gtr:otherNames>Wei L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>doi_55faa2aa21615967</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8211830A-B5B2-497B-8088-6CDE19C9BBD8</gtr:id><gtr:title>The impact of renin-angiotensin-aldosterone system blockade on heart failure outcomes and mortality in patients identified to have aortic regurgitation: a large population cohort study.</gtr:title><gtr:parentPublicationTitle>Journal of the American College of Cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e1f20ff87cdec4acb365bdff39f6ea2"><gtr:id>6e1f20ff87cdec4acb365bdff39f6ea2</gtr:id><gtr:otherNames>Elder DH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0735-1097</gtr:issn><gtr:outcomeId>WTHNhZvmLtr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DDC06CB-67D0-499C-A232-CD31A1444E88</gtr:id><gtr:title>Channelling of SSRIs and SNRIs use in the Tayside population, Scotland.</gtr:title><gtr:parentPublicationTitle>Pharmacoepidemiology and drug safety</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6896965694e7fbd859e84e527852135a"><gtr:id>6896965694e7fbd859e84e527852135a</gtr:id><gtr:otherNames>Wei L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1053-8569</gtr:issn><gtr:outcomeId>C1FBD1B1A14</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33986261-BA79-4F80-A797-D4E960EFBF80</gtr:id><gtr:title>Nurse-led Early Triage (NET) study of chest pain patients: a long term evaluation study of a service development aimed at improving the management of patients with non-ST-elevation acute coronary syndromes.</gtr:title><gtr:parentPublicationTitle>European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/abf0764c34dcce03b00e229ab7953458"><gtr:id>abf0764c34dcce03b00e229ab7953458</gtr:id><gtr:otherNames>O'Neill L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1474-5151</gtr:issn><gtr:outcomeId>pm_16060_20_23644476</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9649A604-A326-4D26-B729-932A490DE268</gtr:id><gtr:title>Is there an interaction between the cardiovascular protective effects of low-dose aspirin and ibuprofen?</gtr:title><gtr:parentPublicationTitle>Basic &amp; clinical pharmacology &amp; toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf8d5efc3393ef9a13e625223ce098ec"><gtr:id>bf8d5efc3393ef9a13e625223ce098ec</gtr:id><gtr:otherNames>MacDonald TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1742-7835</gtr:issn><gtr:outcomeId>23CCA58ED2A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5BA566DA-A5D9-42E3-80D5-4C347AE902FA</gtr:id><gtr:title>Estimated GFR reporting is associated with decreased nonsteroidal anti-inflammatory drug prescribing and increased renal function.</gtr:title><gtr:parentPublicationTitle>Kidney international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6896965694e7fbd859e84e527852135a"><gtr:id>6896965694e7fbd859e84e527852135a</gtr:id><gtr:otherNames>Wei L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0085-2538</gtr:issn><gtr:outcomeId>pm_16060_20_23486517</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CAE15293-4AFD-4B9B-9E9B-4A26932C4EF5</gtr:id><gtr:title>Effect of statins on total cholesterol concentrations and cardiovascular outcomes in patients with diabetes mellitus: a population-based cohort study.</gtr:title><gtr:parentPublicationTitle>European journal of clinical pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/909a4d7a380f419bb49565dc0c798161"><gtr:id>909a4d7a380f419bb49565dc0c798161</gtr:id><gtr:otherNames>Sheng X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0031-6970</gtr:issn><gtr:outcomeId>pm_16060_20_22354153</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F326E31-AAB7-499B-AF04-FA8FBF9A2448</gtr:id><gtr:title>Multicentre, prospective, randomised, open-label, blinded end point trial of the efficacy of allopurinol therapy in improving cardiovascular outcomes in patients with ischaemic heart disease: protocol of the ALL-HEART study.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c51f5c4fb3008a3699b60acdb804c77"><gtr:id>2c51f5c4fb3008a3699b60acdb804c77</gtr:id><gtr:otherNames>Mackenzie IS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>58b5964c073102.38797381</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>716A30F0-E0E4-4102-B593-76C2D1D052BD</gtr:id><gtr:title>Spironolactone use and risk of incident cancers: a retrospective, matched cohort study.</gtr:title><gtr:parentPublicationTitle>British journal of clinical pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c51f5c4fb3008a3699b60acdb804c77"><gtr:id>2c51f5c4fb3008a3699b60acdb804c77</gtr:id><gtr:otherNames>Mackenzie IS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0306-5251</gtr:issn><gtr:outcomeId>58b5964c625650.56800292</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF1448AB-AF18-4584-9B7D-44D833650B35</gtr:id><gtr:title>Promoting public awareness of randomised clinical trials using the media: the 'Get Randomised' campaign.</gtr:title><gtr:parentPublicationTitle>British journal of clinical pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c51f5c4fb3008a3699b60acdb804c77"><gtr:id>2c51f5c4fb3008a3699b60acdb804c77</gtr:id><gtr:otherNames>Mackenzie IS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0306-5251</gtr:issn><gtr:outcomeId>CJMaEcg86YA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B744DDB-8E2A-46CF-8A42-BBDC00F15348</gtr:id><gtr:title>Prognostic effects of selective serotonin reuptake inhibitors in patients with coronary artery bypass grafting.</gtr:title><gtr:parentPublicationTitle>The American journal of cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6896965694e7fbd859e84e527852135a"><gtr:id>6896965694e7fbd859e84e527852135a</gtr:id><gtr:otherNames>Wei L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0002-9149</gtr:issn><gtr:outcomeId>8C89A65BB4A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D136B823-C8D6-40F2-A56D-FBD19DC03EC9</gtr:id><gtr:title>Is the relationship between syndromes of depression and dementia temporal? The MRC-ALPHA and Hefei-China studies.</gtr:title><gtr:parentPublicationTitle>Psychological medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/236f4fb0ad950ba127647144b62c1fce"><gtr:id>236f4fb0ad950ba127647144b62c1fce</gtr:id><gtr:otherNames>Chen R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0033-2917</gtr:issn><gtr:outcomeId>23F307D253E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C530629-4C8B-4379-9DFE-C4207D2F4C44</gtr:id><gtr:title>Effect of statins on total cholesterol concentrations, cardiovascular morbidity, and all-cause mortality in chronic obstructive pulmonary disease: a population-based cohort study.</gtr:title><gtr:parentPublicationTitle>Clinical therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/909a4d7a380f419bb49565dc0c798161"><gtr:id>909a4d7a380f419bb49565dc0c798161</gtr:id><gtr:otherNames>Sheng X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0149-2918</gtr:issn><gtr:outcomeId>pm_16060_20_22244052</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB4DBB3E-38FE-4D9D-8485-E85DDCD05B53</gtr:id><gtr:title>Association of passive smoking with cognitive impairment in nonsmoking older adults: a systematic literature review and a new study of Chinese cohort.</gtr:title><gtr:parentPublicationTitle>Journal of geriatric psychiatry and neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/236f4fb0ad950ba127647144b62c1fce"><gtr:id>236f4fb0ad950ba127647144b62c1fce</gtr:id><gtr:otherNames>Chen R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0891-9887</gtr:issn><gtr:outcomeId>pm_16060_20_23877565</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68F18AA9-5EF1-450B-94A0-1FE7EE4FD8E6</gtr:id><gtr:title>Hypertriglyceridemia and acute pancreatitis.</gtr:title><gtr:parentPublicationTitle>JAMA internal medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bd2a5fbf1ca6037285906634e3bb319"><gtr:id>2bd2a5fbf1ca6037285906634e3bb319</gtr:id><gtr:otherNames>Murphy MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2168-6106</gtr:issn><gtr:outcomeId>pm_16060_20_23183821</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83326E03-6295-4DFF-B499-CCBC2101EA45</gtr:id><gtr:title>Antiplatelet drug interactions.</gtr:title><gtr:parentPublicationTitle>Journal of internal medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c51f5c4fb3008a3699b60acdb804c77"><gtr:id>2c51f5c4fb3008a3699b60acdb804c77</gtr:id><gtr:otherNames>Mackenzie IS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0954-6820</gtr:issn><gtr:outcomeId>gDRh32SaVQD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B69ABFF2-FDEF-4B4C-AF3F-8DF8B6D69D95</gtr:id><gtr:title>Impact of allopurinol use on urate concentration and cardiovascular outcome.</gtr:title><gtr:parentPublicationTitle>British journal of clinical pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6896965694e7fbd859e84e527852135a"><gtr:id>6896965694e7fbd859e84e527852135a</gtr:id><gtr:otherNames>Wei L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0306-5251</gtr:issn><gtr:outcomeId>kNUW3vmRuCx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3DE3A9E-6A77-426F-8DF2-2B865BFCE4A0</gtr:id><gtr:title>Hospital Admissions due to Dysglycaemia and Prescriptions of Antidiabetic Medications in England and Wales: An Ecological Study.</gtr:title><gtr:parentPublicationTitle>Diabetes therapy : research, treatment and education of diabetes and related disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58d2bfac05971ebb1a27bfec1a537867"><gtr:id>58d2bfac05971ebb1a27bfec1a537867</gtr:id><gtr:otherNames>Naser AY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:outcomeId>5a9fc2134d0b20.60142865</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>522E2759-FB1E-4D3B-8382-BA46E00D646B</gtr:id><gtr:title>Pioglitazone and bladder cancer: a propensity score matched cohort study.</gtr:title><gtr:parentPublicationTitle>British journal of clinical pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6896965694e7fbd859e84e527852135a"><gtr:id>6896965694e7fbd859e84e527852135a</gtr:id><gtr:otherNames>Wei L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0306-5251</gtr:issn><gtr:outcomeId>pm_16060_20_22574756</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1CDBC5EF-47BC-47C7-B869-A8953F03F4A1</gtr:id><gtr:title>Effectiveness of statins in chronic kidney disease.</gtr:title><gtr:parentPublicationTitle>QJM : monthly journal of the Association of Physicians</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/909a4d7a380f419bb49565dc0c798161"><gtr:id>909a4d7a380f419bb49565dc0c798161</gtr:id><gtr:otherNames>Sheng X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1460-2393</gtr:issn><gtr:outcomeId>pm_16060_20_22383690</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E850AEC-7AA8-45F9-9364-5762611B3E3D</gtr:id><gtr:title>Improving the primary prevention of cardiovascular events by using biomarkers to identify individuals with silent heart disease.</gtr:title><gtr:parentPublicationTitle>Journal of the American College of Cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50379a40e76ecafb8c515f69e95eb8b8"><gtr:id>50379a40e76ecafb8c515f69e95eb8b8</gtr:id><gtr:otherNames>Nadir MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0735-1097</gtr:issn><gtr:outcomeId>pm_16060_20_22921971</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9E8E3D5-D44E-41D4-9EC0-B186898E69A5</gtr:id><gtr:title>Managing security and privacy concerns over data storage in healthcare research.</gtr:title><gtr:parentPublicationTitle>Pharmacoepidemiology and drug safety</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c51f5c4fb3008a3699b60acdb804c77"><gtr:id>2c51f5c4fb3008a3699b60acdb804c77</gtr:id><gtr:otherNames>Mackenzie IS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1053-8569</gtr:issn><gtr:outcomeId>aA4QVSfUeE7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9B7F047-08FB-4699-9FC0-3027766047CB</gtr:id><gtr:title>Spironolactone and risk of incident breast cancer in women older than 55 years: retrospective, matched cohort study.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c51f5c4fb3008a3699b60acdb804c77"><gtr:id>2c51f5c4fb3008a3699b60acdb804c77</gtr:id><gtr:otherNames>Mackenzie IS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>pm_16060_20_22797844</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19E9C5D2-1DF8-442E-A9AA-5BFFA64EC425</gtr:id><gtr:title>Nigella sativa Supplementation Improves Asthma Control and Biomarkers: A Randomized, Double-Blind, Placebo-Controlled Trial.</gtr:title><gtr:parentPublicationTitle>Phytotherapy research : PTR</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4dd5db5540c7b94655c987de371782d"><gtr:id>c4dd5db5540c7b94655c987de371782d</gtr:id><gtr:otherNames>Koshak A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0951-418X</gtr:issn><gtr:outcomeId>58b596ae429542.54964172</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38E24F00-C768-4D74-B9B6-90039BDAE97A</gtr:id><gtr:title>Cardiovascular safety of lumiracoxib: a meta-analysis of randomised controlled trials in patients with osteoarthritis.</gtr:title><gtr:parentPublicationTitle>European journal of clinical pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c51f5c4fb3008a3699b60acdb804c77"><gtr:id>2c51f5c4fb3008a3699b60acdb804c77</gtr:id><gtr:otherNames>Mackenzie IS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0031-6970</gtr:issn><gtr:outcomeId>pm_16060_20_22732767</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42AE7AFD-E3FE-421A-AF00-16304CE89952</gtr:id><gtr:title>Adherence to statin or aspirin or both in patients with established cardiovascular disease: exploring healthy behaviour vs. drug effects and 10-year follow-up of outcome.</gtr:title><gtr:parentPublicationTitle>British journal of clinical pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6896965694e7fbd859e84e527852135a"><gtr:id>6896965694e7fbd859e84e527852135a</gtr:id><gtr:otherNames>Wei L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0306-5251</gtr:issn><gtr:outcomeId>FB82B0B5A13</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5AA9BB9F-1434-4384-B2A0-EBFC3F84E2FE</gtr:id><gtr:title>Cluster randomized trials of prescription medicines or prescribing policy: public and general practitioner opinions in Scotland.</gtr:title><gtr:parentPublicationTitle>British journal of clinical pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c51f5c4fb3008a3699b60acdb804c77"><gtr:id>2c51f5c4fb3008a3699b60acdb804c77</gtr:id><gtr:otherNames>Mackenzie IS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0306-5251</gtr:issn><gtr:outcomeId>pm_16060_20_22288609</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE921539-171A-45E5-B9D3-D0A7D347A96D</gtr:id><gtr:title>Association between allopurinol and mortality in heart failure patients: a long-term follow-up study.</gtr:title><gtr:parentPublicationTitle>International journal of clinical practice</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6896965694e7fbd859e84e527852135a"><gtr:id>6896965694e7fbd859e84e527852135a</gtr:id><gtr:otherNames>Wei L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1368-5031</gtr:issn><gtr:outcomeId>6D595C3F508</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6CDAB89-392B-44CE-B727-DBE96B990BB2</gtr:id><gtr:title>Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT).</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b06fcf295cf74e8a623e0c973c8664fb"><gtr:id>b06fcf295cf74e8a623e0c973c8664fb</gtr:id><gtr:otherNames>Macdonald TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>pm_16060_20_23364320</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6A7D355-2A82-4E50-9542-275ECC57AE6C</gtr:id><gtr:title>The association between coeliac disease and cardiovascular disease.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6896965694e7fbd859e84e527852135a"><gtr:id>6896965694e7fbd859e84e527852135a</gtr:id><gtr:otherNames>Wei L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>CCEA5B5036C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CAA34A95-2D8C-41D9-B075-D4D7D439B28F</gtr:id><gtr:title>Beliefs about medicines and non-adherence in patients with stroke, diabetes mellitus and rheumatoid arthritis: a cross-sectional study in China.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6896965694e7fbd859e84e527852135a"><gtr:id>6896965694e7fbd859e84e527852135a</gtr:id><gtr:otherNames>Wei L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>5a9fc27eeb43d4.35308292</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9B94A5C-C56A-480B-9EC9-6101C3CE1123</gtr:id><gtr:title>Association between prior appendectomy and/or tonsillectomy in women and subsequent pregnancy rate: a cohort study.</gtr:title><gtr:parentPublicationTitle>Fertility and sterility</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6896965694e7fbd859e84e527852135a"><gtr:id>6896965694e7fbd859e84e527852135a</gtr:id><gtr:otherNames>Wei L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0015-0282</gtr:issn><gtr:outcomeId>58b5954d6606c0.60648461</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E299551D-6BEE-4C63-95FD-7554507AA646</gtr:id><gtr:title>Incident dementia in a defined older Chinese population.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/236f4fb0ad950ba127647144b62c1fce"><gtr:id>236f4fb0ad950ba127647144b62c1fce</gtr:id><gtr:otherNames>Chen R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>LgmXZFX21Wr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF5A6651-17D5-43E2-9762-0CC61B1A475F</gtr:id><gtr:title>Impact on cardiovascular events of increasing high density lipoprotein cholesterol with and without lipid lowering drugs.</gtr:title><gtr:parentPublicationTitle>Heart (British Cardiac Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6896965694e7fbd859e84e527852135a"><gtr:id>6896965694e7fbd859e84e527852135a</gtr:id><gtr:otherNames>Wei L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1355-6037</gtr:issn><gtr:outcomeId>EC7AB412502</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E80BCAB-1D4E-4394-88CC-8E085F8F27CE</gtr:id><gtr:title>A comparison between B-type natriuretic peptide, global registry of acute coronary events (GRACE) score and their combination in ACS risk stratification.</gtr:title><gtr:parentPublicationTitle>Heart (British Cardiac Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11e9341f95d876162b24959dd158ddba"><gtr:id>11e9341f95d876162b24959dd158ddba</gtr:id><gtr:otherNames>Ang DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1355-6037</gtr:issn><gtr:outcomeId>fSA2AsrQpYw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8841BEB-B16D-4A87-A595-B13B8A2DAE7F</gtr:id><gtr:title>Association between appendicectomy in females and subsequent pregnancy rate: a cohort study.</gtr:title><gtr:parentPublicationTitle>Fertility and sterility</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6896965694e7fbd859e84e527852135a"><gtr:id>6896965694e7fbd859e84e527852135a</gtr:id><gtr:otherNames>Wei L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0015-0282</gtr:issn><gtr:outcomeId>pm_16060_20_22683011</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C64D630A-208F-44A3-B9AB-9614047C5B58</gtr:id><gtr:title>The comparative effectiveness of statin therapy in selected chronic diseases compared with the remaining population.</gtr:title><gtr:parentPublicationTitle>BMC public health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/909a4d7a380f419bb49565dc0c798161"><gtr:id>909a4d7a380f419bb49565dc0c798161</gtr:id><gtr:otherNames>Sheng X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-2458</gtr:issn><gtr:outcomeId>pm_16060_20_22935195</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49A2A481-9760-4346-95E4-A77AD9B34F2D</gtr:id><gtr:title>Medicines Optimisation Assessment Tool (MOAT): a prognostic model to target hospital pharmacists' input to improve patient outcomes. Protocol for an observational study.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fcee1d5247cd328f1e0127d7697c513"><gtr:id>2fcee1d5247cd328f1e0127d7697c513</gtr:id><gtr:otherNames>Geeson C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>5a9fc33cabfff6.37277607</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91780DA9-9273-47F8-AF8F-630B624D7A47</gtr:id><gtr:title>Second-hand smoke and dementia.</gtr:title><gtr:parentPublicationTitle>Epidemiology (Cambridge, Mass.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/236f4fb0ad950ba127647144b62c1fce"><gtr:id>236f4fb0ad950ba127647144b62c1fce</gtr:id><gtr:otherNames>Chen R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1044-3983</gtr:issn><gtr:outcomeId>pm_16060_20_23732741</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41A43C5D-6682-407E-B3A3-3BA4BF1B5F61</gtr:id><gtr:title>Tetramethylpyrazine upregulates the aquaporin 8 expression of hepatocellular mitochondria in septic rats.</gtr:title><gtr:parentPublicationTitle>The Journal of surgical research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/315a53dee898f2a150ecf2b55a8d1ee7"><gtr:id>315a53dee898f2a150ecf2b55a8d1ee7</gtr:id><gtr:otherNames>Wang JQ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-4804</gtr:issn><gtr:outcomeId>pm_16060_20_23830368</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6DC2B66-825D-4CB4-9FC5-F13DD40E8AD3</gtr:id><gtr:title>Severity of depression and risk for subsequent dementia: cohort studies in China and the UK.</gtr:title><gtr:parentPublicationTitle>The British journal of psychiatry : the journal of mental science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/236f4fb0ad950ba127647144b62c1fce"><gtr:id>236f4fb0ad950ba127647144b62c1fce</gtr:id><gtr:otherNames>Chen R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0007-1250</gtr:issn><gtr:outcomeId>jL9qXZXUJh1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2EA1A65C-849F-4BFC-AAE3-81DB822F6A52</gtr:id><gtr:title>Impact of renin-angiotensin system blockade therapy on outcome in aortic stenosis.</gtr:title><gtr:parentPublicationTitle>Journal of the American College of Cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50379a40e76ecafb8c515f69e95eb8b8"><gtr:id>50379a40e76ecafb8c515f69e95eb8b8</gtr:id><gtr:otherNames>Nadir MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0735-1097</gtr:issn><gtr:outcomeId>QYZX3phvGyp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6B41153-0DAF-4B34-AC1B-ACA91B8B92EA</gtr:id><gtr:title>Co-prescription of co-trimoxazole and spironolactone in elderly patients.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6896965694e7fbd859e84e527852135a"><gtr:id>6896965694e7fbd859e84e527852135a</gtr:id><gtr:otherNames>Wei L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>J2PAP2yEQwE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C8D5DB5-1062-4546-9330-C720839D69C0</gtr:id><gtr:title>Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT).</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf8d5efc3393ef9a13e625223ce098ec"><gtr:id>bf8d5efc3393ef9a13e625223ce098ec</gtr:id><gtr:otherNames>MacDonald TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn><gtr:outcomeId>58b5964baec3a9.47668934</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A57FAFA1-A251-47B0-850B-BDB7325CCDBB</gtr:id><gtr:title>Statins and total (not LDL) cholesterol concentration and outcome of myocardial infarction: results from a meta-analysis and an observational study.</gtr:title><gtr:parentPublicationTitle>European journal of clinical pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/909a4d7a380f419bb49565dc0c798161"><gtr:id>909a4d7a380f419bb49565dc0c798161</gtr:id><gtr:otherNames>Sheng X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0031-6970</gtr:issn><gtr:outcomeId>19C15923E25</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B98B44D-9C06-4795-8823-B7A2C2DCE39E</gtr:id><gtr:title>Impact on mortality following first acute myocardial infarction of distance between home and hospital: cohort study.</gtr:title><gtr:parentPublicationTitle>Heart (British Cardiac Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6896965694e7fbd859e84e527852135a"><gtr:id>6896965694e7fbd859e84e527852135a</gtr:id><gtr:otherNames>Wei L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1355-6037</gtr:issn><gtr:outcomeId>5817F370FB3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA3717C5-A0A3-4B47-9C03-44199FBB9C7A</gtr:id><gtr:title>Effectiveness of two statin prescribing strategies with respect to adherence and cardiovascular outcomes: observational study.</gtr:title><gtr:parentPublicationTitle>Pharmacoepidemiology and drug safety</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6896965694e7fbd859e84e527852135a"><gtr:id>6896965694e7fbd859e84e527852135a</gtr:id><gtr:otherNames>Wei L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1053-8569</gtr:issn><gtr:outcomeId>FCEjB5bpLei</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3FF7E7B9-9C6D-4987-809B-78B85310032E</gtr:id><gtr:title>Effectiveness of statins on total cholesterol and cardiovascular disease and all-cause mortality in osteoarthritis and rheumatoid arthritis.</gtr:title><gtr:parentPublicationTitle>The Journal of rheumatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/909a4d7a380f419bb49565dc0c798161"><gtr:id>909a4d7a380f419bb49565dc0c798161</gtr:id><gtr:otherNames>Sheng X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0315-162X</gtr:issn><gtr:outcomeId>kLnHVK8nhPw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A8324DF-B62A-47D8-B2A6-D33682A32A29</gtr:id><gtr:title>'Real-life' reduction in cholesterol with statins, 1993 to 2002.</gtr:title><gtr:parentPublicationTitle>British journal of clinical pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bd2a5fbf1ca6037285906634e3bb319"><gtr:id>2bd2a5fbf1ca6037285906634e3bb319</gtr:id><gtr:otherNames>Murphy MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0306-5251</gtr:issn><gtr:outcomeId>mAqVDssd2hP</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G106/1249</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>712BA5B2-EB41-48F7-A933-F9EFA1D3314B</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>7.1  Individual care needs</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>